טוען...
Higher post-induction infliximab concentrations are associated with improved clinical outcomes in fistulizing Crohn’s disease: an ACCENT-II post-hoc analysis
OBJECTIVES: There are only limited data regarding the role of therapeutic drug monitoring in fistulizing Crohn’s disease (CD). We investigated the association between both induction and maintenance serum infliximab concentrations and favorable therapeutic outcomes in patients with fistulizing CD. ME...
שמור ב:
| הוצא לאור ב: | Am J Gastroenterol |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8095681/ https://ncbi.nlm.nih.gov/pubmed/33929379 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14309/ajg.0000000000001111 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|